AP
EVMN

Andera Partners’s Evommune Inc EVMN Stock Holding History

Andera Partners’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5M Sell
1,391,990
-505,372
-27% -$11.7M 8.96% 5
2026
Q1 		$43.6M Hold
1,897,362
– – 24.66% 2
2025
Q4 		$32.5M Buy
+1,897,362
New +$35.6M 18.39% 3

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Andera Partners's EVMN Position: Q2 2026 in Review

Andera Partners reduced its Evommune Inc (EVMN) stake by 27% in Q2 2026, selling an estimated $11.7M and leaving 1,391,990 shares worth $18.5M. The position accounts for 8.96% of the portfolio, ranked #5.

Andera Partners first reported a position in EVMN in Q4 2025 and has held it in 3 quarters since. The position peaked at $43.6M in Q1 2026. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Andera Partners held 1,391,990 shares of Evommune Inc worth $18.5M as of Q2 2026.
  • Andera Partners sold 505,372 Evommune Inc shares in Q2 2026, an estimated $11.7M.
  • Evommune Inc made up 8.96% of Andera Partners's portfolio in Q2 2026, its #5 holding.
  • Andera Partners first reported a position in Evommune Inc in Q4 2025 and has held it in 3 quarters since.
  • Andera Partners's Evommune Inc position peaked at $43.6M in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Andera Partners's 13F filing for Q2 2026, filed 22 Jul 2026.